Koninklijke Ahold N.V. AHODF Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Koninklijke Ahold N.V. AHODF Company Overview 

Stock Message Board http://investorshangout.com/search?q=AHODF&am...mp;yt1=Go!

Koninklijke Ahold N.V. AHODF Current Price and Quotes
16.358
Previous Close
16.358
Open
N/A

Daily Range
N/A - N/A
52wk Range
17.235 - 11.93

Volume
0
Dividend
N/A

Average Vol (3m)
3,275
Yield
N/A

Koninklijke Ahold N.V. AHODF
Company Information
Provincialeweg 11
Zaandam 1506 MA
Netherlands

Website: http://www.ahold.com
Phone: +31 (0)88 659 5213

Koninklijke Ahold N.V. AHODF
Ahold is an international food retailing group based in the Netherlands, operating leading supermarket companies in Europe and the United States. Ahold's supermarkets are powerful local brands with a strong focus on the customer, offering great value, a convenient and innovative shopping experience and a wide range of products and healthy choices. At the end of 2012, Ahold had 3,074 stores, 225,000 employees and total sales of 32.8 billion Euros.

Koninklijke Ahold N.V. AHODF
Financial Reportings and Disclosures
Reporting Status International Reporting: Euronext Amsterdam
Deregistered a/o Sep 28, 2007
Latest Report Jul 14, 2013 Interim Financial Report
CIK 0000869425
Fiscal Year End 12/30
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification 5411 - Grocery stores
Incorporated In: Netherlands
Year of Inc. 1973
Employees 212527 a/o Jan 02, 2011
Company Officers/Contacts
Dick Boer CEO, COO
Jeff Carr CFO
Lodewijk Hijmans van den Bergh EVP, Chief Corp. Gov. Counsel
Company Directors
Rene Dahan Chairman
Company Notes
U.S. Office: Ahold U.S.A. Holdings, Inc., One Atlanta Plaza, 950 East Paces Ferry Rd, Suite 2575, Atlanta, GA 30326. U.S. Phone: 404-262-6050
Service Providers
Auditor/Accountant
PricewaterhouseCoopers
201 Sussex Street
Sydney, NSW, 1171
Australia

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Koninklijke Ahold N.V. AHODF
AHODF Security Details Other Company Securities
Share Structure
Market Value1 $17,788,556,174 a/o Aug 30, 2013
Shares Outstanding 1,087,453,000 a/o Oct 09, 2011
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
AH - Euronext Amsterdam - Qualified
Short Selling Data
Short Interest 83,461 (-4.49%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)


Koninklijke Ahold N.V. AHODF Recent News


Aug 26, 2013 Ahold share buyback update
Aug 22, 2013 Ahold appoints new Chief Human Resources Officer
Aug 22, 2013 Ahold publishes second quarter and half year 2013 results
Aug 19, 2013 Park City Group Welcomes Private Label Marketing Veteran Bill Wolfe to Leadership Team
Aug 16, 2013 Marley Coffee Now Distributed in Ahold Supermarket Chains
Aug 9, 2013 American Realty Capital Trust V to Acquire $1.45 Billion of Net Lease Properties
Jul 2, 2013 Deutsche Bank Appointed as Successor Depositary Bank for the Level I American Depositary Receipt Program of Koninklijke Ahold N.V.
Jun 18, 2013 Ahold announces new executive leadership structure and the appointment of a new Chief Commercial Officer (CCO)
Jun 12, 2013 Harris Williams & Co. Ltd Opens German Office; Firm Appoints Jeffery Perkins as Head
Jun 12, 2013 Ahold CEO elected new co-chair of Consumer Goods Forum

12next >

Koninklijke Ahold N.V. AHODF Financials
Period Ending Dec 31, 2012 Jan 01, 2012
Total Revenue 43,419,000 39,297,000
Cost of Revenue 32,150,000 29,014,000
Gross Profit 11,270,000 10,283,000
Operating Expenses
Research and Development - -
Sales, General and Admin. 9,700,000 8,534,000
Non-Recurring Items - -
Other - -
Operating Income 1,569,000 1,749,000
Income From Continuing Operations
Add'l Income/Expense Items 12,000 (92,000)
Earnings Before Interest and Tax 1,581,000 1,656,000
Interest Expense 312,000 318,000
Earnings Before Tax 1,269,000 1,338,000
Income Tax 279,000 182,000
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary 107,000 183,000
Net Income Cont. Operations 1,097,000 1,340,000
Non Recurring Events
Discontinued Operations (4,000) (19,000)
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income 1,093,000 1,320,000
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders 1,093,000 1,320,000

AHODF Koninklijke Ahold N.V. Research DD Guide

AHODF Koninklijke Ahold N.V. Stock Message Board http://investorshangout.com/search?q=AHODF&am...mp;yt0=Go!
AHODF Koninklijke Ahold N.V. Stock Quote http://www.otcmarkets.com/stock/AHODF/quote
AHODF Koninklijke Ahold N.V. Stock Chart http://www.otcmarkets.com/stock/AHODF/chart
AHODF Koninklijke Ahold N.V. Company Info http://www.otcmarkets.com/stock/AHODF/company-info
AHODF Koninklijke Ahold N.V. Recent News http://www.otcmarkets.com/stock/AHODF/news
AHODF Koninklijke Ahold N.V. Financials http://www.otcmarkets.com/stock/AHODF/financials
AHODF Koninklijke Ahold N.V. Filings and Disclosure http://www.otcmarkets.com/stock/AHODF/filings
AHODF Koninklijke Ahold N.V. Short Sales http://www.otcmarkets.com/stock/AHODF/short-sales
AHODF Koninklijke Ahold N.V. Insider Disclosure http://www.otcmarkets.com/stock/AHODF/insider-transactions
AHODF Koninklijke Ahold N.V. Research Reports http://www.otcmarkets.com/stock/AHODF/research
AHODF Koninklijke Ahold N.V. Summary http://finance.yahoo.com/q?s=AHODF
AHODF Koninklijke Ahold N.V. Historical Prices http://finance.yahoo.com/q/hp?s=AHODF+Historical+Prices
AHODF Koninklijke Ahold N.V. Interactive Chart http://finance.yahoo.com/echarts?s=AHODF
AHODF Koninklijke Ahold N.V. Basic Chart http://finance.yahoo.com/q/bc?s=AHODF+Basic+Chart
AHODF Koninklijke Ahold N.V. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AHODF+Basic+Tech.+Analysis
AHODF Koninklijke Ahold N.V. Headlines http://finance.yahoo.com/q/h?s=AHODF+Headlines
AHODF Koninklijke Ahold N.V. Press Releases http://finance.yahoo.com/q/p?s=AHODF+Press+Releases
AHODF Koninklijke Ahold N.V. Company Profile http://finance.yahoo.com/q/pr?s=AHODF+Profile
AHODF Koninklijke Ahold N.V. Key Statistics http://finance.yahoo.com/q/ks?s=AHODF+Key+Statistics
AHODF Koninklijke Ahold N.V. Industry http://finance.yahoo.com/q/in?s=AHODF+Industry
AHODF Koninklijke Ahold N.V. Major Holders http://finance.yahoo.com/q/mh?s=AHODF+Major+Holders
AHODF Koninklijke Ahold N.V. Insider Transactions http://finance.yahoo.com/q/it?s=AHODF+Insider+Transactions
AHODF Koninklijke Ahold N.V. Insider Roster http://finance.yahoo.com/q/ir?s=AHODF+Insider+Roster
AHODF Koninklijke Ahold N.V. Income Statement http://finance.yahoo.com/q/is?s=AHODF
AHODF Koninklijke Ahold N.V. Balance Sheet http://finance.yahoo.com/q/bs?s=AHODF
AHODF Koninklijke Ahold N.V. Cash Flow http://finance.yahoo.com/q/cf?s=AHODF+Cash+Flow&annual
AHODF Koninklijke Ahold N.V. Nasdaq http://www.nasdaq.com/symbol/AHODF
AHODF Koninklijke Ahold N.V. Market Watch http://www.marketwatch.com/investing/stock/AHODF
AHODF Koninklijke Ahold N.V. Bloomberg http://www.bloomberg.com/quote/AHODF:US
AHODF Koninklijke Ahold N.V. Morningstar http://quotes.morningstar.com/stock/s?t=AHODF
AHODF Koninklijke Ahold N.V. Bussinessweek http://investing.businessweek.com/research/st...cker=AHODF
AHODF Koninklijke Ahold N.V. Barchart http://www.barchart.com/quotes/stocks/AHODF
AHODF Koninklijke Ahold N.V. OTC Short Report http://otcshortreport.com/index.php?index=AHODF
AHODF Koninklijke Ahold N.V. Investopedia http://www.investopedia.com/markets/stocks/AHODF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 54

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 70

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 0

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Coastal Financial Faces Class Action Suit Over Securities

Updated Category News Views 78

Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 101

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
MAURE's Three-Year Mark: Crafting Home Elegance

Updated Category News Views 53

Brooklyn's Gem: MAURE Turns Three Over in Brooklyn, there's a brand bubbling with style called MAURE. Now, we're talking three years strong, surviving the wild bout of the retail scene with a firm two feet planted in home and gifting. The Vision Turned Reality When Maureen Cavalieri, a hospitality veteran since 2009, first tossed this spark into the wind in 2023, it...

Continue Reading
Dizal Unveils Promising Data at ASH 2026

Updated Category News Views 72

Pushing the Horizons in Hematological Research From the bustling streets of Shanghai to the global stage of the ASH 2026, Dizal has made its mark again. This year's presentations could very well shake up the hematological landscape, showcasing new possibilities for treatment strategies. Golidocitinib: A Game-Changer? Now here's a ticket we've been watching with some high...

Continue Reading
LOA Roofing's Growth Recap Taps Southstone's Backing

Updated Category News Views 107

Pardon my skepticism, but when a roofing company names itself Life of Abundance, you know they're aiming to hit it big or at least make you think they're onto something special. LOA Roofing and Construction, holding its ground as a major player in the Central Texas market, set the stage for more ambitious growth. And they found themselves a dance partner in Southstone...

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 17

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Eli Lilly's Retatrutide Trials Signal Innovation

Updated Category News Views 48

Unpacking Lilly's Latest Rheumatology Innovations Lilly's taking the stage at ACR Convergence 2026 with a potent arsenal of data that’s got folks buzzing. The company’s put the pedal to the metal on understanding the intertwining chords of obesity and rheumatologic conditions, and boy, are they not messing around. Retatrutide: A Triple Threat in the Making Headlining...

Continue Reading

Top 5 Most Recently Viewed Articles

SKYX Technologies Expands Market Presence with Insider Investments

Updated Category News Views 166

SKYX Technologies' Corporate Developments SKYX Technologies, also known as SKYX (NASDAQ: SKYX), is taking significant strides in the smart technology sector. This dynamic company focuses on transforming homes and buildings into smarter, safer, and more advanced spaces. With a remarkable portfolio of over 97 issued and pending patents, SKYX aims to set a new standard in...

Continue Reading
Crinetics Pharmaceuticals Expands Workforce With Stock Options

Updated Category News Views 195

Crinetics Pharmaceuticals Enhances Employee Incentives In a recent announcement, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), based in San Diego, revealed a significant step in enhancing employee incentives and strengthening its workforce. On October 10, 2025, the company’s Compensation Committee authorized the granting of stock options and restricted stock units...

Continue Reading
Manulife Investment Management Earns Top Recognition in Sustainable Finance

Updated Category News Views 199

Manulife Investment Management Recognized for Excellence In a significant acknowledgment of its leadership in sustainable finance, Manulife Investment Management (Manulife IM) has made it to the prestigious list of IPE Real Assets' Top 50 Natural Capital Managers. This recognition comes as the firm is gearing up for robust fundraising activities, with an exciting fund...

Continue Reading
Vaxart Reports Progress and Financial Performance for Q3 2025

Updated Category News Views 213

Vaxart’s Business Progress and Financial Results Overview Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, recently provided a significant update on its business and reported its financial outcomes for the third quarter of 2025. This latest communication showcases exciting developments in their oral recombinant vaccine platform, which is designed to...

Continue Reading
Madrigal Pharmaceuticals Marks Enrollment Milestone in NASH Study

Updated Category News Views 47

Madrigal Pharmaceuticals Achieves Enrollment Milestone in NASH Study Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, has announced a significant milestone in their MAESTRO-NASH OUTCOMES clinical trial. This study evaluates the efficacy of resmetirom in patients diagnosed with...

Continue Reading